PETERS WILLIAM J sold $184K of AMPH
PETERS WILLIAM J (CFO, EVP & TREASURER) sold 8,180 shares of Amphastar Pharmaceuticals, Inc. (AMPH) at $22.48 ($0.18M total) on 2026-08-07 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosure updates the record of insider ownership and may influence sentiment, but it does not introduce new company fundamentals (no guidance, trial results, or deal terms).
Market read
Traders may monitor AMPH for follow-on insider activity, but the 10b5-1 framing suggests the sale is likely planned rather than reactive.
What to watch
The article does not state whether the sale was part of a broader multi-tranche program, nor does it provide option exercises or other offsetting insider activity that could change net signaling.
Background
This is an SEC Form 4 insider transaction disclosure for Amphastar Pharmaceuticals, Inc. (AMPH).
Ticker impact
Insider Form 4 shows AMPH CFO William J. Peters sold 8,180 shares on 2026-08-07 at $22.48 via a 10b5-1 plan.
Low likelihood of a sustained price move; any reaction is likely muted and short-lived.
The filing is a primary-source Form 4, but the presence of a pre-arranged 10b5-1 plan and the lack of any accompanying fundamental catalyst reduce directional conviction.
Market effects
No clear sector read-through from a single routine insider sale at a biotech/pharma company.
None indicated.
None indicated.
Counterpoint
Even with a 10b5-1 plan, repeated insider selling by senior executives can still be interpreted as a lack of near-term upside conviction by the market.
Key entities
- issuerAmphastar Pharmaceuticals, Inc.
Subject of the Form 4 insider sale disclosure.
- insiderWilliam J. Peters
CFO, EVP & Treasurer who sold shares under a pre-arranged 10b5-1 plan.
